A single dose of neoadjuvant PD1 blockade predicts clinical outcomes in resectable melanoma httpswww.nature.comarticless415910190357yÂAnother interesting paper on neoadjuvant immunotherapy after encouraging data in brain cancerhttpst

A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable #melanoma https://www.nature.com/articles/s41591-019-0357-y … Another interesting paper on neoadjuvant #immunotherapy after encouraging data in brain cancer https://t

19:28 EST 26 Feb 2019 | Andy Biotech

A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable #melanoma https://www.nature.com/articles/s41591-019-0357-y … Another interesting paper on neoadjuvant #immunotherapy after encouraging data in brain cancer https://twitter.com/AndyBiotech/status/1094991735367876608 … pic.twitter.com/Yaewroi0RI

More From BioPortfolio on "A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable #melanoma https://www.nature.com/articles/s41591-019-0357-y … Another interesting paper on neoadjuvant #immunotherapy after encouraging data in brain cancer https://t"